logo
Wildfire Smoke Linked to Respiratory Admissions in Seniors

Wildfire Smoke Linked to Respiratory Admissions in Seniors

Medscape3 days ago

Among older adults in the western United States, exposure to high concentrations of smoke-related fine particulate matter (PM2.5) was associated with increased rates of hospitalizations for respiratory diseases, with weaker but suggestive ties to cardiovascular hospitalizations.
METHODOLOGY:
Researchers carried out a retrospective cohort study to analyze the association between exposure to smoke-specific PM2.5 and cause-specific hospitalizations in older adults in the United States.
They used inpatient claims data of 10,369,361 Medicare beneficiaries (mean age, 74.7 years; 53.1% women) across 11 western United States during wildfire seasons from 2006 to 2016, with 57,974,120 person-months of follow-up.
The causes of unscheduled hospitalizations were inferred from International Classification of Diseases, Ninth Revision, Clinical Modification codes and classified into various disease categories.
codes and classified into various disease categories. Daily concentrations of surface-level smoke-specific PM2.5 were estimated through machine learning models that utilized ground measurements, satellite data, and reanalysis data sources.
The associations between causes of hospitalization and smoke-specific PM2.5 were characterized by examining daily county-level rates of unscheduled hospitalization by disease category, modeling hospitalization rates according to same-day and prior-week smoke-specific PM2.5 exposure.
TAKEAWAY:
The leading cause of unscheduled hospitalizations was cardiovascular disease, with a mean daily rate of 7.92 per 100,000 persons, followed by digestive system disease at 3.62 and respiratory disease at 3.53 per 100,000 persons.
Respiratory hospitalizations increased as smoke-specific PM2.5 exceeded 25 μg/m 3 , with average daily rates increasing by 2.40 (95% CI, 0.17-4.63) per 100,000 persons when PM2.5 levels rose from 0 to 40 μg/m 3 over a week.
, with average daily rates increasing by 2.40 (95% CI, 0.17-4.63) per 100,000 persons when PM2.5 levels rose from 0 to 40 μg/m over a week. Hospitalizations due to cardiovascular diseases were unrelated to smoke-specific PM2.5 at exposure levels < 20 μg/m 3 but showed an increasing trend at higher concentrations.
but showed an increasing trend at higher concentrations. No significant associations were seen for hospitalizations related to injuries, digestive issues, neuropsychiatric conditions, or endocrine disorders.
IN PRACTICE:
'This information can be used by both policymakers and clinicians to design policies and guidelines to protect vulnerable older adults from the escalating health threats posed by wildfire smoke,' the authors wrote.
SOURCE:
This study was led by Sofia L. Vega, Harvard T.H. Chan School of Public Health, Boston. It was published online on April 30, 2025, in JAMA Network Open .
LIMITATIONS:
Estimating concentrations of smoke-specific PM2.5 proved challenging due to the lack of direct measurements. County-level exposure measures may not have accurately reflected the exposures experienced by individual residents. This study did not include information on wildfires from recent years when their intensity increased.
DISCLOSURES:
This study was supported by the Harvard Climate Change Solutions Fund and grants from the National Institutes of Health. One author reported receiving support through an environmental fellowship at the Harvard University Center. The authors reported having no conflicts of interest.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

I Thought I Was Washing My Bath Towels Often Enough. I Was Dead Wrong
I Thought I Was Washing My Bath Towels Often Enough. I Was Dead Wrong

CNET

time32 minutes ago

  • CNET

I Thought I Was Washing My Bath Towels Often Enough. I Was Dead Wrong

When it comes to cleaning our homes, bathrooms are at the top of the list. While we often clean the obvious parts of the bathroom, it's easy to overlook less visible dirty items -- like bath towels. Even though your bathroom towels may look clean -- after all, they're usually just drying off clean parts of your body -- they could be holding massive amounts of bacteria and germs. I'm often guilty of ignoring my bath towels. As long as they're dry and back in place, I rarely give them a second thought. But to keep myself and my housemates healthy, I'll make a point to wash them more regularly. Learn how often you should wash your bath towels to keep them in tip-top shape and the best temperature for getting the cleanest. Why do you need to clean your bath towels so often? When you dry off with towels, they get moist. This porous, damp environment is the perfect breeding ground for bacteria. A common bath towel can have yeast, mold and E. coli growing on it without you ever knowing it. Gross, right? Regular washing prevents bacteria from growing. LG's WashTower functions as one combined washer and dryer unit. LG When should you reuse or wash bathroom towels? Consumer Reports says that under normal circumstances, a towel can be used three or four times before it needs to be washed. That's "times" not "days." If you have many family members using a towel (like hand towels), it needs to be washed on the third or fourth use. The condition of the person using the towel matters, too. If they're sick, toss it in the laundry after one use. If it's flu season, it's best for every family member to have their own towel -- even if they aren't exhibiting symptoms -- to prevent the potential spread of germs. How often you wash towels also depends on how they're dried after usage. If towels find themselves on the floor, the lack of air circulation will cause bacteria to grow quickly. To prolong the life of your towel, be sure to place damp towels on a towel rack. Better yet, crack open a window or turn on the fan to reduce moisture in the room. Supercharge your dryer by cleaning its vent Supercharge your dryer by cleaning its vent Click to unmute Video Player is loading. Play Video Pause Skip Backward Skip Forward Next playlist item Unmute Current Time 0:04 / Duration 1:37 Loaded : 18.39% 0:04 Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 1:33 Share Fullscreen This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Text Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Opaque Semi-Transparent Transparent Caption Area Background Color Black White Red Green Blue Yellow Magenta Cyan Opacity Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Drop shadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset Done Close Modal Dialog End of dialog window. Close Modal Dialog This is a modal window. This modal can be closed by pressing the Escape key or activating the close button. Close Modal Dialog This is a modal window. This modal can be closed by pressing the Escape key or activating the close button. Supercharge your dryer by cleaning its vent What temperature is best for washing bath towels? The Infection Control department of Mid-Western Regional Hospital of Ennis, Ireland, recommends washing towels in water that is at least 140 degrees Fahrenheit (60 degrees Celsius) or more to kill bacteria. So if you have a sanitize mode on your washing machine, use it. If not, you may consider raising the temperature on your water heater while washing that load. Be sure young children are supervised around sinks, tubs and showers while you do laundry, though, to prevent burns. And, before you reach for the fabric softener, don't. Fabric softener leaves residue on towels that makes them less absorbent.

Who would want to have babies under a Trump administration? Not me.
Who would want to have babies under a Trump administration? Not me.

USA Today

time34 minutes ago

  • USA Today

Who would want to have babies under a Trump administration? Not me.

Who would want to have babies under a Trump administration? Not me. | Opinion The Trump administration does not care about what is medically necessary to save someone's life. They care about controlling women. Why would anybody want to have a child under that way of thinking? Show Caption Hide Caption Trump rescinds Biden-era emergency abortion care guidance The Trump administration rescinded guidance clarifying that hospitals in abortion-ban states must treat pregnant patients during medical emergencies. unbranded - Newsworthy Despite declarations that something needs to be done about the declining birth rate in the United States, neither President Donald Trump nor the Republican Party has the desire to protect pregnant people. If they did, the Trump administration wouldn't have made its latest move to restrict abortion nationwide. On Tuesday, June 3, the Centers for Medicare and Medicaid Services rescinded a Biden-era policy that directed hospitals to provide emergency abortions if it was needed to stabilize a pregnant patient. The guidance and communications on it apparently 'do not reflect the policy of this Administration.' I, like many people who support abortion rights, know what this will lead to. It means more pregnant people will die. Does that reflect the policy of the administration? Having a baby in America is dangerous. Republicans aren't helping. The Biden policy was implemented in 2022, following the fall of Roe v. Wade, and argued that hospitals receiving Medicare funding had to comply with the Emergency Medical Treatment and Active Labor Act (EMTALA). The former administration argued that this included providing emergency abortions when they were needed to stabilize a patient, even in states that had severe abortion restrictions. Opinion: A brain dead pregnant Georgia woman is a horror story. It's Republicans' fault. This wasn't entirely a surprise. In 2024, the Supreme Court ruled that Texas could ban virtually all abortions in the state, including abortions that would have occurred under the old EMTALA guidelines. Still, it's terrifying to see this crucial policy eliminated. It's already dangerous to be pregnant in the United States. Our maternal mortality rate is much higher than in other wealthy countries. Same with our infant mortality rate. This will only exacerbate these tragedies. In states with abortion bans, the risks are even greater. A study from the Gender Equity Policy Institute found that people living in states with abortion bans were twice as likely to die during or shortly after childbirth. This is also backed by anecdotal evidence, including the 2022 deaths of two women in Georgia after the state passed a six-week ban. A different study found that infant mortality rates increased in states with severe restrictions on abortion, including an increase in deaths due to congenital anomalies. The Trump administration does not care about what is medically necessary to save someone's life. They don't care about whether the children supposedly saved by rescinding this policy will grow up without their mother. They care about their perceived moral superiority. They care about controlling women. Why would anybody want to have a child under that Republican way of thinking? Opinion: We're worrying about the wrong thing. Low birth rate isn't the crisis: Child care is. None of this is surprising from Republicans. It's just sad. I want to say I'm surprised that the Trump administration would allow women in need of emergency care to die. Yet this is clearly aligned with the Republican stance on abortion, just like it's aligned with the actions that the party has taken to make it harder for women to access necessary care. Whether you like it or not, abortion is a necessary part of health care. It saves lives. Alexis McGill Johnson, the president and CEO of Planned Parenthood, laid it out plainly. 'Women have died because they couldn't get the lifesaving abortion care they needed,' she said in a statement. 'The Trump administration is willing to let pregnant people die, and that is exactly what we can expect." Again, this is the administration that wants young women like me to have children and improve the country's birth rate. This is an administration that claims to care about women and children. I know I wouldn't want to have a child while Trump continues to make it unsafe to be pregnant and give birth. I hate that this is the reality. Follow USA TODAY columnist Sara Pequeño on X, formerly Twitter, @sara__pequeno

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment
Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment

Yahoo

time36 minutes ago

  • Yahoo

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment

Discover the future of the Molecular Diagnostics - Infectious Disease sector with our comprehensive report. Explore how multiplex assays and rapid testing are transforming diagnosis and treatment amidst the boom in biotechnology and genomics. This detailed analysis covers dynamic trends such as pathogen evolution, globalization, and climate change impacts. Benefit from extensive insights, including U.S. Medicare Fee Schedules, and detailed global data. Equip your organization with expert knowledge today. Dublin, June 06, 2025 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides" report has been added to offering. The Molecular Diagnostics - Infectious Disease sector of the clinical diagnostics industry is poised for further growth. A market that just keeps on growing but is becoming more complex and segmented. Find out what's happening in this informative report - and find out about the impact of multiplex assays which threaten to change diagnosis and treatment forever. The report has hundreds of pages of information including a complete list of Current United States Medicare Fee Payment Schedules to help sharpen your pricing along with the most frequently used and billed tests. The report includes detailed breakouts for 15 countries and 4 regions. A detailed breakout for any country in the world is available to purchasers of the report. This research makes you the expert in your organization. Assistance and additional specific data is provided without additional charges. All report data is available in Excel format on request. Exciting technical developments especially in the seesaw between nucleic acid testing and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Infectious disease testing directly benefits from the explosion in biotechnology, especially genomics. Learn all about it in this report. A range of dynamic trends are pushing market growth and company valuations. Trends like: Multiplex testing Pathogen evolution and pandemics Biotechnology advances in genetics Climate change Globalization The rise of rapid testing Key Topics Covered: 1 Market Guides1.1 Situation Analysis2 Introduction and Market Definition2.1 Market Definition2.1.1 Market Size2.1.2 Currency2.1.3 Years2.2 Methodology2.2.1 Methodology2.2.2 Sources2.2.3 Authors2.3 Perspective: Healthcare Spending2.3.1 Global Healthcare Spending2.3.2 Spending on Healthcare and Pharmaceuticals2.3.3 Spending on Diagnostics2.3.4 Important Role of Insurance for Medical Services2.4 The Nature of the IVD Product2.4.1 Features Overview2.4.2 The Misunderstood Feature2.4.3 Regulation2.4.4 The Newest Feature2.4.5 The Oldest Feature2.4.6 All About Scope2.4.7 Why Turnaround is Becoming More Important2.4.8 The Role of Trust2.5 The IVD Product of the Future3 Infectious Diseases - Guide to the Pathogens3.1 Infectious Disease Pathogens - The Big Picture3.1.1 Viruses3.1.2 Bacteria3.1.3 Fungi3.1.4 Parasites3.1.5 Prions3.1.6 Virulence3.1.7 Transmission3.2 The Coronavirus3.2.1 Severe acute respiratory syndrome (SARS)3.2.2 Middle East respiratory syndrome (MERS)3.2.3 COVID-19. The SARS CoV 2 Virus3.2.3.1 Signs and symptoms3.2.3.2 Transmission3.2.3.3 Diagnosis3.2.3.4 Prevention3.2.3.5 Management3.2.3.6 Prognosis4 Industry Overview4.1 Players in a Dynamic Market4.1.1 Academic Research Lab4.1.2 Diagnostic Test Developer4.1.3 Instrumentation Supplier4.1.4 Chemical/Reagent Supplier4.1.5 Pathology Supplier4.1.6 Independent Clinical Laboratory4.1.7 Public National/regional Laboratory4.1.8 Hospital Laboratory4.1.9 Physicians Office Lab (POLS)4.1.10 Audit Body4.1.11 Certification Body4.2 The Clinical Laboratory Market Segments4.2.1 Traditional Market Segmentation4.2.2 Laboratory Focus and Segmentation4.2.3 Segmenting the Syndromic Testing Market4.3 Industry Structure4.3.1 Hospital Testing Share4.3.2 Economies of Scale4.3.3 Hospital vs. Central Lab4.3.4 Physician Office Lab's4.3.5 Physician's and POCT5 Market Trends5.1 Factors Driving Growth5.1.1 The Nucleic Acid Impact5.1.2 Population Dynamics5.1.3 The Developing World5.1.4 Decentralization5.1.5 Self Testing5.1.6 The Need for Speed5.2 Factors Limiting Growth5.2.1 Costs and Experience Curve Effects5.2.2 The Role of ID Prevalence5.2.3 Wellness5.2.4 The Impact of Living Standards5.3 Instrumentation, Automation and Diagnostic Trends5.3.1 Traditional Automation and Centralization5.3.2 The New Automation, Decentralization and Point of Care5.3.3 Instruments Key to Market Share5.3.4 Bioinformatics Plays a Role5.3.5 PCR Takes Command5.3.6 Next Generation Sequencing Fuels a Revolution5.3.7 NGS Impact on Pricing5.3.8 Whole Genome Sequencing, A Brave New World5.3.9 Companion Diagnostics Blurs Diagnosis and Treatment6 Clinical Laboratory MDx Infectious Disease Recent Developments6.1 Recent Developments - Importance and How to Use This Section6.1.1 Importance of These Developments6.1.2 How to Use This Section6.2 Presymptom Health Nabs Funding for Sepsis Test6.3 FDA Clears BioMerieux GI Panel6.4 Rapid Infection Diagnostic Launches BSIDx6.5 Biotia's AI-, Sequencing-Based UTI Test approved6.6 Delve Bio, Broad Clinical Labs Partner for Metagenomic6.7 Roche Respiratory Panel Receives FDA EUA6.8 Genetic Signatures Gets Approval for GI Parasite Panel6.9 Diasorin Expands Respiratory Panel6.10 BioMerieux Outlines MDx-Driven Growth6.11 T2 Biosystems Gets Extended T2Bacteria Panel6.12 Diasorin Aims to Deliver Updated Instruments, New Assays6.13 Oxford Nanopore Nabs Investment From BioMerieux6.14 Day Zero Diagnostics Closes Financing Round6.15 Spindiag Seeks Investors for Rapid PCR System6.16 Sorrento Therapeutics Nabs Contract for Dx Platform6.17 Kephera Planning Menu of Infectious Disease Tests6.18 Oxford Nanopore and BioMerieux to Develop IDDx6.19 SD Biosensor Eyes Global Expansion6.20 Selux Dx Next Gen Phenotyping Gets FDA Clearance6.21 Takara Developing High-Throughput Multiplex Panels6.22 BioGX Debuts New Point-of-Care Molecular Testing System6.23 Nanopath MDx Platform Providing 15-Minute Results6.24 ProtonDx Commercializing Rapid MDx Instrument6.25 Hologic Obtains CE Mark for MDx Epstein-Barr, BK Virus Assays6.26 Pathogenomix Infectious Disease Platform Uses Cloud-Based Analytics, NGS6.27 Accelerate Diagnostics Anticipates Growth6.28 Lumos Diagnostics Expanding Test Portfolio6.29 Study Validates Karius Cell-Free DNA to Detect Hundreds of Pathogens7 Key Companies7.1 Abbott Laboratories7.2 Agilent7.3 Altona Diagnostics7.4 Anitoa7.5 Autonomous Medical Devices7.6 Beckman Coulter Diagnostics (Danaher)7.7 Becton, Dickinson and Company7.8 BioGX7.9 Biomatik7.10 bioMerieux Diagnostics7.11 Bio-Rad Laboratories, Inc.7.12 Cepheid (Danaher)7.13 Diasorin S.p.A.7.14 DNAe7.15 Flow Health7.16 Global Access Diagnostics7.17 Great Basin Scientific, Inc.7.18 Hologic7.19 Novacyt7.20 Novus Diagnostics7.21 Oncimmune7.22 One Codex7.23 OraSure Technologies7.24 Prometheus Laboratories7.25 Qiagen7.26 QuidelOrtho7.27 R-Biopharm AG7.28 Response Biomedical7.29 Revvity7.30 Roche Diagnostics7.31 Siemens Healthineers7.32 Thermo Fisher Scientific7.33 Vela Diagnostics7.34 Veredus Laboratories7.35 YD Diagnostics7.36 Zhejiang Orient Gene Biotech8 The Global Market for Clinical Laboratory MDx Infectious Disease8.1 Global Market Overview by Country8.2 Global Market by Application - Overview8.3 Global Market by Place - Overview9 Global Clinical Laboratory MDx Infectious Disease Markets - By Application9.1 Respiratory9.2 Blood Borne Virus9.3 Transplant9.4 Hospital Acquired Infections9.5 Reproductive Health9.6 C19 Singleplex9.7 Meningitis9.8 Gastrointestinal9.9 Tropical10 Global Clinical Laboratory MDx Infectious Disease Markets - By Place10.1 Hospital Lab10.2 Outpatient Lab10.3 Point of Care10.4 Other Place11 Appendices11.1 Growth of Approved IVD Test Menu11.2 Growth of Approved Average IVD Test Fee11.3 The Most Used IVD Assays11.4 The Highest Grossing Assays11.5 Laboratory Fees Schedule For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store